Current Seminars
25/10/2011 - 18:30 -
China: Marketing Pfizer's Sutent for Gastrointestinal Tumors
Sunitinib malate (Sutent®) is a small-molecular inhibitor of tyrosine kinase receptors produced by Pfizer. It is used in the treatment of patients with gastrointestinal stromal tumours (GIST), a rare disease that affects the gastrointestinal tract. Patients suffering from GIST who develop resistance to or do not respond to the first-line...
18/10/2011 - 18:30 -
Amgen V Transkaryotic Therapies: The Legal Battle Over Recombinant Erythropoietin
The patent infringement lawsuit between Amgen and Transkaryotic Therapies (TKT) over recombinant erythropoietin, a multibillion dollar biologic, is one of the most famous intellectual property cases in biotechnology. The patent protection of Amgen’s first blockbuster product, Epogen, was threatened by TKT's comparable product Dynepo....
04/10/2011 - 18:30 -
Raising Financing
Raising Financing
Guest Speaker: Grant Tipler, Head, Life Sciences and Healthcare Markets, RBC
Location: Instructional Centre, Room 335.
All welcome!
27/09/2011 - 18:30 -
Medical Device Regulatory Environment - Combination Devices
Medical Device Regulatory Environment - Combination Devices
Guest speaker: Marisa Petrielli, Director, Regulatory Affairs, Clinical Studies & Quality Assurance, Biotronik
Instructional Centre, Room 335. All welcome!
20/09/2011 - 18:30 -
Emerging Markets and Healthcare
Emerging Markets and Healthcare
Guest speaker: Martin Gurbin, VP Sunnybrook International, Sunnybrook Hospital
Location: Instructional Centre, Room 335. All welcome!